Back to top

Image: Bigstock

Should You Buy Assembly Biosciences (ASMB) After Golden Cross?

Read MoreHide Full Article

Assembly Biosciences, Inc. (ASMB - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ASMB's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross."

There's a reason traders love a golden cross -- it's a technical chart pattern that can indicate a bullish breakout is on the horizon. This kind of crossover is formed when a stock's short-term moving average breaks above a longer-term moving average. Typically, a golden cross involves the 50-day and the 200-day moving averages, since bigger time periods tend to form stronger breakouts.

A successful golden cross event has three stages. It first begins when a stock's price on the decline bottoms out. Then, its shorter moving average crosses above its longer moving average, triggering a positive trend reversal. The third and final phase occurs when the stock maintains its upward momentum.

This kind of chart pattern is the opposite of a death cross, which is a technical event that suggests future bearish price movement.

Shares of ASMB have been moving higher over the past four weeks, up 36.6%. Plus, the company is currently a #2 (Buy) on the Zacks Rank, suggesting that ASMB could be poised for a breakout.

The bullish case solidifies once investors consider ASMB's positive earnings outlook. For the current quarter, no earnings estimate has been cut compared to 1 revision higher in the past 60 days. The Zacks Consensus Estimate has increased too.

Moving Average Chart for ASMB

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on ASMB for more gains in the near future.

Published in